Alzheimer disease blood biomarkers and cognition in midlife
AD pathology and neurodegeneration indicated by blood biomarkers may already start contributing to cognitive function in midlife. Young and middle adulthood is a critical time for AD prevention, which may delay the onset of cognitive decline and dementia among middle-aged and older adults.
Authors
- Ilya M. Nasrallah (ORCID: https://orcid.org/0000-0003-2346-7562)
- L. Shaw
- Xiaqing Jiang (ORCID: https://orcid.org/0000-0003-3633-0688)
- David R. Jacobs
- Tina Hoang
- Kristine Yaffe
- R Nick Bryan
Institutions
- University of Minnesota (US)
- University of California, San Francisco (US)
- University of Pennsylvania Health System (US)
- Northern California Institute for Research and Education (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_101201
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00